There was a certain biotech ETF I started eyeing last December. I had looked at a few biotech mutual funds and ETFs and, after researching which companies were the dominant holdings, I settled on one of the funds. Before I could get around to actually buying, though, the price started to rise. So I waited. And waited. You know how this story ends. (As I write this, the ETF I had settled on, but never bought, is up 124% for the year.)
All Financial Planning articles are archived after 7 days. REGISTER NOW for unlimited access to all recently archived articles, as well as thousands of searchable stories. Registered Members also gain access to exclusive industry white paper downloads, web seminars, blog discussions, the iPad App, CE Exams, and conference discounts. Qualified members may also choose to receive our free monthly magazine and any of our daily or weekly e-newsletters covering the latest breaking news, opinions from industry leaders, developing trends and growth strategies.